David Shaw’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
David Shaw's OPRX Position: Q2 2026 in Review
David Shaw reduced its OptimizeRx (OPRX) stake by 3.4% in Q2 2026, selling an estimated $27.8K and leaving 138,084 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #3913.
David Shaw first reported a position in OPRX in Q4 2020 and has held it in 18 quarters since. The position peaked at $7.66M in Q2 2023. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- David Shaw held 138,084 shares of OptimizeRx worth $790K as of Q2 2026.
- David Shaw sold 4,839 OptimizeRx shares in Q2 2026, an estimated $27.8K.
- OptimizeRx made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3913 holding.
- David Shaw first reported a position in OptimizeRx in Q4 2020 and has held it in 18 quarters since.
- David Shaw's OptimizeRx position peaked at $7.66M in Q2 2023.
- 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.